COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.
Hematol Oncol
; 41(3): 555-558, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-36786526
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
COVID-19
/
Multiple Myeloma
Limits:
Humans
Language:
En
Journal:
Hematol Oncol
Year:
2023
Document type:
Article
Affiliation country:
Italia
Country of publication:
Reino Unido